Press releases & Media

Press releases

• Stockholm3 in the Swedish national guidelines for prostate cancer
  August 9, 2022
• Stockholm3 study is named the best scientific publication by the European Association of Urology
  July 5, 2022
• A3P Biomedical initiates partnership with Unilabs for Stockholm3
  June 16, 2022

More press releases

A3P in media

• Stena Sessan, EQT founder Thomas von Koch and one of Sweden’s leading life science investors invest in A3P Biomedical.
  May 6, 2022
• Finally time for public screening of prostate cancer? (In Swedish)
  November 22, 2021
• Stockholm3, in combination with MRI, make general screening of prostate cancer possible (in Swedish)
  October 6, 2021

More articles